Genmab A/S Foreign Exchange Loss
Genmab A/S (GNMSF) reported Foreign Exchange Loss of $161.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ForeignExchangeLoss · last filed 2026-02-17
DKK
| Period end | Foreign Exchange Loss 6 month | Foreign Exchange Loss 12 month |
|---|---|---|
| 2024-06-30 | 316.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 889.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 439.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 1.05B DKK 6-K · filed 2025-02-12 | |
| 2020-12-31 | 1.46B DKK 6-K · filed 2023-02-22 |
USD
| Period end | Foreign Exchange Loss 12 month |
|---|---|
| 2025-12-31 | $161.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $166.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $66.00M 20-F · filed 2026-02-17 |